Evidence map›Paper›PMID 32505128›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018.

Sara S Kim, Brendan Flannery, Ivo M Foppa, Jessie R Chung, Mary Patricia Nowalk, Richard K Zimmerman, Manjusha Gaglani, Arnold S Monto, Emily T Martin, Edward A Belongia and 4 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Influenza vaccine effectiveness against outpatient acute respiratory illness with laboratory-confirmed influenza, United States, 2024-25 season.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sara S KimInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Brendan FlanneryInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ivo M FoppaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jessie R ChungInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mary Patricia NowalkUniversity of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania, USA.
Richard K ZimmermanUniversity of Pittsburgh Schools of the Health Sciences, Pittsburgh, Pennsylvania, USA.
Manjusha GaglaniBaylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
Arnold S MontoUniversity of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Emily T MartinUniversity of Michigan School of Public Health, Ann Arbor, Michigan, USA.
Edward A BelongiaMarshfield Clinical Research Institute, Marshfield, Wisconsin, USA.
Huong Q McLeanMarshfield Clinical Research Institute, Marshfield, Wisconsin, USA.
Michael L JacksonKaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Lisa A JacksonKaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Manish PatelInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse networkU01IP001035 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2016 to 2020
$7.8M
Mandatory_Estimates of Vaccine Effectiveness Against Medically-Attended, PCR-Confirmed Influenza in West South Central U.S.U01IP001039 · IP · SCOTT AND WHITE MEMORIAL HOSPITAL · PI GAGLANI, MANJUSHA · 2016 to 2020
$6.5M
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness ResearchU01IP000474 · IP · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MONTO, ARNOLD S · 2011 to 2015
$6.2M
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a LargeU01IP000467 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2011 to 2015
$5.9M
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin PopulationU01IP000471 · IP · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI BELONGIA, EDWARD · 2011 to 2015
$5.6M
Core_Prospective population-based estimation of influenza vaccine effectiveness aU01IP000466 · IP · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI JACKSON, MICHAEL L · 2011 to 2015
$4.1M
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine EffectivenessU01IP000473 · IP · SCOTT AND WHITE MEMORIAL HOSPITAL · PI GAGLANI, MANJUSHA · 2011 to 2015
$4.0M
ACL HHS U01IP001034ACL HHS U01IP001039NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1 TR001857NCIRD CDC HHS U01 IP000466NCIRD CDC HHS U01 IP000467NCIRD CDC HHS U01 IP000471NCIRD CDC HHS U01 IP000473NCIRD CDC HHS U01 IP000474NCIRD CDC HHS U01 IP001034NCIRD CDC HHS U01 IP001035NCIRD CDC HHS U01 IP001038NCIRD CDC HHS U01 IP001039NCRR NIH HHS UL1 RR024153
6 · The paper itself

Abstract

backgroundWe compared effects of prior vaccination and added or lost protection from current season vaccination among those previously vaccinated.

methodsOur analysis included data from the US Flu Vaccine Effectiveness Network among participants ≥9 years old with acute respiratory illness from 2012-2013 through 2017-2018. Vaccine protection was estimated using multivariate logistic regression with an interaction term for effect of prior season vaccination on current season vaccine effectiveness. Models were adjusted for age, calendar time, high-risk status, site, and season for combined estimates. We estimated protection by combinations of current and prior vaccination compared to unvaccinated in both seasons or current vaccination among prior vaccinated.

resultsA total of 31 819 participants were included. Vaccine protection against any influenza averaged 42% (95% confidence interval [CI], 38%-47%) among those vaccinated only the current season, 37% (95% CI, 33-40) among those vaccinated both seasons, and 26% (95% CI, 18%-32%) among those vaccinated only the prior season, compared with participants vaccinated neither season. Current season vaccination reduced the odds of any influenza among patients unvaccinated the prior season by 42% (95% CI, 37%-46%), including 57%, 27%, and 55% against A(H1N1), A(H3N2), and influenza B, respectively. Among participants vaccinated the prior season, current season vaccination further reduced the odds of any influenza by 15% (95% CI, 7%-23%), including 29% against A(H1N1) and 26% against B viruses, but not against A(H3N2).

conclusionsOur findings support Advisory Committee on Immunization Practices recommendations for annual influenza vaccination. Benefits of current season vaccination varied among participants with and without prior season vaccination, by virus type/subtype and season.

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesChildHumansInfluenza A Virus, H3N2 SubtypeInfluenza B virusSeasonsUnited StatesVaccinationInfluenza Vaccinesinfluenzaprior vaccinationrepeat vaccinationvaccine effectivenessvaccines

Identifiers

PMID32505128
PMCPMC8326585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.